Valuation: Berkley Renewables Inc.

Market Cap 364K 318K 297K 273K 512K 34.85M 524K 3.51M 1.37M 17.26M 1.37M 1.34M 59.53M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.47M 4.17M 3.84M 7.2M 490M 7.37M 49.37M 19.33M 243M 19.24M 18.83M 837M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 20/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 17/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+3.47%+0.48%+21.69%+1.84% 139B
+4.61%+3.16%+48.87%+63.34% 92.18B
+4.51%+1.74%+19.97%+11.66% 74.38B
+4.64%-0.34%+32.29%+36.73% 53.54B
+3.89%-0.83%+23.01%-9.75% 53.64B
+4.53%+0.57%+98.11%+63.39% 51.88B
+4.22%+0.82%+30.42%-16.11% 49.2B
+1.39%+4.77%+25.01%-13.89% 42.83B
+1.76%+5.56%+1.27%+24.34% 32.31B
Average +3.30%-1.13%+33.40%+17.95% 58.9B
Weighted average by Cap. +3.84%-1.72%+33.39%+18.83%

Financials

2016 2017
Net sales 1.03M 902K 842K 774K 1.45M 98.9M 1.49M 9.96M 3.9M 48.99M 3.88M 3.8M 169M 1.72M 1.5M 1.4M 1.29M 2.42M 165M 2.48M 16.61M 6.5M 81.71M 6.48M 6.33M 282M
Net income 173K 151K 141K 129K 242K 16.52M 248K 1.66M 651K 8.18M 648K 634K 28.21M -631K -550K -513K -472K -885K -60.3M -907K -6.07M -2.38M -29.87M -2.37M -2.32M -103M
Net Debt 2.92M 2.54M 2.37M 2.18M 4.1M 279M 4.2M 28.1M 11M 138M 10.95M 10.71M 477M 4.76M 4.15M 3.88M 3.56M 6.68M 455M 6.85M 45.86M 17.95M 226M 17.87M 17.49M 778M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-